Trial · NCT02383173
Evaluation of Methods for Implementation of a Comfort Care Order Set
NCT02383173, Not applicable, Completed, VA Office of Research and Development; results first posted 2020-12-08
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Evaluation of Methods for Implementation of a Comfort Care Order Set. Trials, record NCT02383173. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02383173
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Evaluation of Methods for Implementation of a Comfort Care Order Set
- NCT number
- NCT02383173
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 134 participants, actual
- Lead sponsor
- VA Office of Research and Development
- Conditions
- Terminal Conditions, End of Life
- Interventions
- Basic Implementation Approach, Enhanced Implementation Approach
- First posted
- 2015-03-09
- Last updated
- 2023-07-27
- Results first posted
- 2020-12-08
- Limitations and caveats
- Analyses limited by baseline values on some key endpoints
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Presence of an Active Opioid Order at Time of Death | at time of death for veterans who died in the 9 months following the intervention period | presence of an active opioid order at time of death in Veteran's medical record |
| Secondary | Presence of an Order for Benzodiazepine Medication | last 7 days of life for veterans who died in the 9 months following the intervention period | presence of an order for benzodiazepine medication in the last 7 days of life |
| Secondary | Presence of a Do-not-resuscitate Order | last 7 days of life for veterans who died in the 9 months following the intervention period | presence of a do-not-resuscitate order in the last 7 days of life |
| Secondary | Presence of a Palliative Care Consult Order | last 7 days of life for veterans who died in the 9 months following the intervention period | presence of a palliative care consult order in the last 7 days of life |
| Secondary | Location of Death | in the 9 months following the intervention period | death in intensive care unit |
| Secondary | Presence of a Nasogastric Tube | in the 9 months following the intervention period | presence of a nasogastric tube at time of death |
| Secondary | Presence of an Intravenous Line | in the 9 months following the intervention period | presence of an intravenous line at time of death |
| Secondary | Presence of Restraints | in the 9 months following the intervention period | presence of restraints at time of death |
| Secondary | Presence of a Pastoral Care Visit | last 7 days of life for veterans who died in the 9 months following the intervention period | presence of a pastoral care visit in the last 7 days of life |
Source ClinicalTrials.gov
Outcomes9
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Presence of an Active Opioid Order at Time of Death | at time of death for veterans who died in the 9 months following the intervention period | Veterans who died as inpatients in acute care units of VA Medical Centers | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Presence of an Order for Benzodiazepine Medication | last 7 days of life for veterans who died in the 9 months following the intervention period | Veterans who died in the 9 months following the intervention period | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Presence of a Do-not-resuscitate Order | last 7 days of life for veterans who died in the 9 months following the intervention period | Veterans who died as inpatients in acute care units of VA Medical Centers | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Presence of a Palliative Care Consult Order | last 7 days of life for veterans who died in the 9 months following the intervention period | Veterans who died as inpatients in acute care units of VA Medical Centers | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Location of Death | in the 9 months following the intervention period | Veterans who died as inpatients in acute care units of VA Medical Centers | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Presence of a Nasogastric Tube | in the 9 months following the intervention period | Veterans who died as inpatients in acute care units of VA Medical Centers | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Presence of an Intravenous Line | in the 9 months following the intervention period | Veterans who died as inpatients in acute care units of VA Medical Centers | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Presence of Restraints | in the 9 months following the intervention period | Veterans who died as inpatients in acute care units of VA Medical Centers | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Presence of a Pastoral Care Visit | last 7 days of life for veterans who died in the 9 months following the intervention period | Veterans who died as inpatients in acute care units of VA Medical Centers | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Presence of an Active Opioid Order at Time of Death | Basic Implementation Approach | 1330 | Participants | ||
| Presence of an Active Opioid Order at Time of Death | Enhanced Implementation Approach | 1543 | Participants | ||
| Presence of an Order for Benzodiazepine Medication | Basic Implementation Approach | 1025 | Participants | ||
| Presence of an Order for Benzodiazepine Medication | Enhanced Implementation Approach | 1117 | Participants | ||
| Presence of a Do-not-resuscitate Order | Basic Implementation Approach | 1336 | Participants | ||
| Presence of a Do-not-resuscitate Order | Enhanced Implementation Approach | 1504 | Participants | ||
| Presence of a Palliative Care Consult Order | Basic Implementation Approach | 1208 | Participants | ||
| Presence of a Palliative Care Consult Order | Enhanced Implementation Approach | 1426 | Participants | ||
| Location of Death | Basic Implementation Approach | 436 | Participants | ||
| Location of Death | Enhanced Implementation Approach | 408 | Participants |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Basic Implementation Approach | 88 | 23 |
| Overall Study | STARTED | Enhanced Implementation Approach | 46 | 24 |
| Overall Study | COMPLETED | Basic Implementation Approach | 88 | 23 |
| Overall Study | COMPLETED | Enhanced Implementation Approach | 44 | 23 |
| Overall Study | NOT COMPLETED | Basic Implementation Approach | 0 | 0 |
| Overall Study | NOT COMPLETED | Enhanced Implementation Approach | 2 | 1 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Basic Implementation Approach | 0 | 0 |
| Total, all-cause mortality | Enhanced Implementation Approach | 0 | 0 |
| Total, other adverse events | Basic Implementation Approach | 0 | 0 |
| Total, other adverse events | Enhanced Implementation Approach | 0 | 0 |
| Total, serious adverse events | Basic Implementation Approach | 0 | 0 |
| Total, serious adverse events | Enhanced Implementation Approach | 0 | 0 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 33547573 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons9
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Basic Implementation Approach vs Enhanced Implementation Approach: Presence of a Do-not-resuscitate Order | Trial comparisons |
| Basic Implementation Approach vs Enhanced Implementation Approach: Presence of a Palliative Care Consult Order | Trial comparisons |
| Basic Implementation Approach vs Enhanced Implementation Approach: Presence of an Intravenous Line | Trial comparisons |
| Basic Implementation Approach vs Enhanced Implementation Approach: Presence of a Nasogastric Tube | Trial comparisons |
| Basic Implementation Approach vs Enhanced Implementation Approach: Location of Death | Trial comparisons |
| Basic Implementation Approach vs Enhanced Implementation Approach: Presence of a Pastoral Care Visit | Trial comparisons |
| Basic Implementation Approach vs Enhanced Implementation Approach: Presence of an Order for Benzodiazepine Medication | Trial comparisons |
| Basic Implementation Approach vs Enhanced Implementation Approach: Presence of Restraints | Trial comparisons |
| Basic Implementation Approach vs Enhanced Implementation Approach: Presence of an Active Opioid Order at Time of Death | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02383173
GET https://conductscience.org/api/trials/v1/NCT02383173/registered